American Hospital Dubai signs MOU with 10XREVIV to advance longevity care in UAE

UAE—American Hospital Dubai and Abu Dhabi-based health technology company 10XREVIV have signed a non-binding memorandum of understanding (MoU) to explore precision medicine, preventive healthcare and longevity services in the UAE and the wider region.

10XREVIV operates in precision nutrition, women’s health, longevity, advanced therapeutics and human optimization medicine.

Its technology portfolio includes MYiOX Health, a consumer health platform, and MYiOX Pro, software designed for clinicians. The company also provides nutritional engineering and genetic analysis services.

Integrating health data into clinical care

Under the MoU, the partners will explore integrating the MYiOX Health and MYiOX Pro platforms with American Hospital Dubai’s systems.

The proposed collaboration covers precision nutrition, longevity and healthy ageing, supportive oncology programmes, clinician education and research.

The agreement also provides for support for American Hospital Dubai’s Centre of Excellence in longevity and healthy ageing.

The MYiOX platforms are designed to connect personal wellness data with clinical care by combining genetic information, biomarkers, nutrition data and artificial intelligence (AI).

The approach aims to help healthcare professionals develop more personalized interventions and track health outcomes.

Sherif Beshara, Group CEO of American Hospital Dubai, said the agreement supports the hospital’s efforts to advance healthcare delivery in the UAE and the wider region.

He noted that integrating personal health data into clinical practice could help people make more informed health decisions and translate individual measurements into practical interventions.

He added that interoperability between the hospital’s medical infrastructure and 10XREVIV’s technology could create opportunities to expand personalized medicine.

Focus on prevention and healthy ageing

Brandon Dawson, Chairman and Co-Founder of 10XREVIV, said the company welcomed the collaboration with American Hospital Dubai, citing the hospital’s focus on clinical care and innovation.

He said the partners intend to use data-driven health tools to support disease prevention, recovery and healthy ageing among patients in the UAE and other regional markets.

Dawson also described the agreement as a milestone in 10XREVIV’s international expansion and its work at the intersection of precision health, technology and longevity.

The collaboration reflects growing interest in using genetic testing, biomarker analysis and AI-enabled platforms to support more individualized healthcare.

For providers, integrating these tools into established clinical systems requires attention to data interoperability, clinical validation, patient privacy and regulatory compliance.

American Hospital Dubai and 10XREVIV will implement any programmes arising from the MoU under the hospital’s clinical governance framework and subject to the relevant UAE regulatory approvals.

Sign up HERE to receive our email newsletters with the latest news and insights from Africa and around the world, and follow us on LinkedIn for updates.